Medicenna Therapeutics Analyst Ratings
Medicenna Therapeutics Analyst Ratings
While ratings are subjective and will change, the latest Medicenna Therapeutics (MDNA) rating was a reiterated with a price target of $0.00 to $2.50. The current price Medicenna Therapeutics (MDNA) is trading at is $0.45, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/31/2023 | 455.56% | HC Wainwright & Co. | → $2.5 | Reiterates | Buy → Buy |
| 06/28/2023 | 455.56% | HC Wainwright & Co. | → $2.5 | Reiterates | Buy → Buy |
| 02/08/2023 | 455.56% | HC Wainwright & Co. | → $2.5 | Reiterates | → Buy |
| 11/08/2022 | 455.56% | HC Wainwright & Co. | $4 → $2.5 | Maintains | Buy |
| 08/16/2022 | 788.89% | HC Wainwright & Co. | $5 → $4 | Maintains | Buy |
| 06/23/2022 | 2122.22% | Oppenheimer | $12 → $10 | Maintains | Outperform |
| 06/23/2022 | 1011.11% | HC Wainwright & Co. | $7 → $5 | Maintains | Buy |
| 06/01/2021 | 1455.56% | HC Wainwright & Co. | $8 → $7 | Maintains | Buy |
| 12/18/2020 | 2566.67% | Oppenheimer | → $12 | Initiates Coverage On | → Outperform |
| 12/17/2020 | 2566.67% | Oppenheimer | → $12 | Initiates Coverage On | → Outperform |
| 09/10/2020 | 1677.78% | HC Wainwright & Co. | → $8 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 07/31/2023 | 455.56% | HC Wainwright & Co. | → 2.5 美元 | 重申 | 购买 → 购买 |
| 06/28/2023 | 455.56% | HC Wainwright & Co. | → 2.5 美元 | 重申 | 购买 → 购买 |
| 02/08/2023 | 455.56% | HC Wainwright & Co. | → 2.5 美元 | 重申 | → 购买 |
| 2022 年 8 月 11 日 | 455.56% | HC Wainwright & Co. | 4 美元 → 2.5 美元 | 维护 | 购买 |
| 08/16/2022 | 788.89% | HC Wainwright & Co. | 5 美元 → 4 美元 | 维护 | 购买 |
| 06/23/2022 | 2122.22% | 奥本海默 | 12 美元 → 10 美元 | 维护 | 跑赢大盘 |
| 06/23/2022 | 1011.11% | HC Wainwright & Co. | 7 美元 → 5 美元 | 维护 | 购买 |
| 06/01/2021 | 1455.56% | HC Wainwright & Co. | 8 美元 → 7 美元 | 维护 | 购买 |
| 2020 年 12 月 18 日 | 2566.67% | 奥本海默 | → 12 美元 | 启动覆盖开启 | → 跑赢大盘 |
| 2020 年 12 月 17 日 | 2566.67% | 奥本海默 | → 12 美元 | 启动覆盖开启 | → 跑赢大盘 |
| 2020 年 10 月 9 日 | 1677.78% | HC Wainwright & Co. | → 8 美元 | 启动覆盖开启 | → 购买 |
What is the target price for Medicenna Therapeutics (MDNA)?
Medicenna Therapeutics（MDNA）的目标价格是多少？
The latest price target for Medicenna Therapeutics (NASDAQ: MDNA) was reported by HC Wainwright & Co. on July 31, 2023. The analyst firm set a price target for $2.50 expecting MDNA to rise to within 12 months (a possible 455.56% upside). 5 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2023年7月31日公布了Medicenna Therapeutics（纳斯达克股票代码：MDNA）的最新目标股价。这家分析公司将目标股价定为2.50美元，预计MDNA将在12个月内升至455.56％（可能上涨455.56％）。去年有5家分析公司公布了评级。
What is the most recent analyst rating for Medicenna Therapeutics (MDNA)?
分析师对Medicenna Therapeutics（MDNA）的最新评级是多少？
The latest analyst rating for Medicenna Therapeutics (NASDAQ: MDNA) was provided by HC Wainwright & Co., and Medicenna Therapeutics reiterated their buy rating.
Medicenna Therapeutics（纳斯达克股票代码：MDNA）的最新分析师评级由HC Wainwright & Co. 提供，Medicenna Therapeutics重申了他们的买入评级。
When is the next analyst rating going to be posted or updated for Medicenna Therapeutics (MDNA)?
Medicenna Therapeutics（MDNA）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Medicenna Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Medicenna Therapeutics was filed on July 31, 2023 so you should expect the next rating to be made available sometime around July 31, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Medicenna Therapeutics的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月进行一次评级，因此每家公司每年应该获得4个评级。Medicenna Therapeutics的最新评级是在2023年7月31日提交的，因此你应该预计下一个评级将在2024年7月31日左右公布。
Is the Analyst Rating Medicenna Therapeutics (MDNA) correct?
分析师对Medicenna Therapeutics（MDNA）的评级正确吗？
While ratings are subjective and will change, the latest Medicenna Therapeutics (MDNA) rating was a reiterated with a price target of $0.00 to $2.50. The current price Medicenna Therapeutics (MDNA) is trading at is $0.45, which is within the analyst's predicted range.
尽管评级是主观的，将会发生变化，但最新的Medicenna Therapeutics（MDNA）评级得到了重申，目标股价为0.00美元至2.50美元。Medicenna Therapeutics（MDNA）目前的交易价格为0.45美元，在分析师的预测区间内。
